Key result
The DOAC Dipstick detected factor Xa inhibitor plasma levels ≥30 ng/mL with 97.4% sensitivity and 68.6% specificity, and dabigatran levels with 100% sensitivity and 97.9% specificity.
Why the study?
An accurate point-of-care test for detecting effective anticoagulation by direct oral anticoagulants in emergencies remains an unmet need.
Does the DOAC Dipstick accurately detect DOAC plasma levels ≥30 ng/mL in adults on DOAC treatment presenting to an emergency department?
Cross-Sectional (n=265)
Blinded to reference standard and clinical data
No
Does the DOAC Dipstick accurately detect DOAC plasma levels ≥30 ng/mL in adults on DOAC treatment presenting to an emergency department?
The DOAC Dipstick is a highly sensitive point-of-care test for detecting relevant DOAC exposure in emergency department patients, though specificity for factor Xa inhibitors is moderate.
Answers are grounded in this paper and cite their sources.
May aid emergency DOAC detection; leaves open prospective validation before clinical use.
An accurate point-of-care test for detecting effective anticoagulation by direct oral anticoagulants (DOACs) in emergencies is an unmet need. We investigated the accuracy of a urinary qualitative strip test (DOAC Dipstick) to detect relevant DOAC exposure in patients who presented to an emergency department. In this prospective single-center cohort-type cross-sectional study, adults on DOAC treatment were enrolled. We assessed clinical sensitivity and specificity of DOAC Dipstick factor Xa and thrombin inhibitor pads to detect DOAC plasma levels ≥30 ng/mL using urine samples as the testing matrix. Liquid chromatography coupled with tandem-mass spectrometry was used as the reference standard method for plasma and urine measurement of DOAC concentrations. Of 293 patients enrolled, 265 patients were included in the analysis, of whom 92 were treated with rivaroxaban, 65 with apixaban, 77 with edoxaban, and 31 with dabigatran. The clinical sensitivity and specificity of the dipstick on urine samples to detect ≥30 ng/mL dabigatran plasma levels were 100% (95% confidence interval [CI]: 87-100%) and 98% (95% CI: 95-99%), respectively. The sensitivity and specificity of the dipstick to detect ≥30 ng/mL factor Xa inhibitor plasma levels were 97% (95% CI: 94-99%) and 69% (95% CI: 56-79%), respectively. The DOAC Dipstick sensitively identified effective thrombin and factor Xa inhibition in a real-world cohort of patients presenting at an emergency department. Therefore, the dipstick might provide a valuable test to detect relevant DOAC exposure in emergencies, although further studies will be needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Merrelaar et al. (2022) conducted a cross-sectional in DOAC exposure in emergency department patients (n=265). DOAC Dipstick vs. Liquid chromatography coupled with tandem-mass spectrometry (LC-MS/MS) was evaluated on Sensitivity to detect ≥30 ng/mL factor Xa inhibitor plasma levels (Sensitivity 97.4%, 95% CI 94.1-99.2). The DOAC Dipstick detected factor Xa inhibitor plasma levels ≥30 ng/mL with 97.4% sensitivity and 68.6% specificity, and dabigatran levels with 100% sensitivity and 97.9% specificity.
Synapse has enriched 10 related papers. Consider them for comparative context: